UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

Benzer Materyaller

• UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
  Yazar:: Turner, R, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.
  Yazar:: Mehta, Z, ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
  Yazar:: Horton, V, ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
  Yazar:: Davis, T, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43)
  Yazar:: Horton, V, ve diğerleri
  Baskı/Yayın Bilgisi: (1999)